Profile picture

Professor Juan Tamargo

Complutense University of Madrid, Madrid (Spain)
Membership: FESC Member
Follow
Biography
Juan Tamargo is Professor of Pharmacology in the School of Medicine of the University Complutense of Madrid (Spain). He graduated as physician, obtained a PhD in Pharmacology and a master’s degree in clinical pharmacology. He completed his postgraduate training in the New York Upstate and Downstate Medical Centres (US) and the Universität des Saarlandes (Germany). He is Member of the Royal National Academies of Pharmacy and Medicine and of the Spanish Institute. His primary research interest is cardiovascular pharmacology, with a focus on cardiac electrophysiology and arrhythmias. He is an editorial board member for: Basic & Clinical Pharmacology & Toxicology, Cardiovascular Drugs and Therapy, European Cardiology Review, Frontiers in Physiology (Cardiac electrophysiology), Frontiers in Drug safety and Regulation, and J. Pharmacological Sciences. Associated Editor of the International Journal of Cardiology and European Heart Journal-Cardiovascular Pharmacotherapy.
Logo ESC

Contributor content

Cardiovascular drug adherence and persistence: relevance and implementation
Session
Cardiovascular drug adherence and persistence: relevance and implementation
30 August 2025
Challenges in antiarrhythmic pharmacotherapy
Session
Challenges in antiarrhythmic pharmacotherapy
4 November 2023
Cardiovascular Pharmacotherapy in Women
Session
Cardiovascular Pharmacotherapy in Women
3 November 2023
The new era of SGLT2 Inhibitors in Cardiovascular Disease: beyond glucose control
Session
The new era of SGLT2 Inhibitors in Cardiovascular Disease: beyond glucose control
3 November 2023
Oral anticoagulation in patients with venous thromboembolism or left ventricular thrombus
Session
Oral anticoagulation in patients with venous thromboembolism or left ventricular thrombus
28 August 2023
Oral anticoagulation in patients with atrial fibrillation
Session
Oral anticoagulation in patients with atrial fibrillation
25 August 2023
Strategies to improve cardiovascular pharmacotherapy in older people
Session
Strategies to improve cardiovascular pharmacotherapy in older people
29 June 2023
Welcome address
Session
Welcome address
28 June 2023
Heart failure with reduced ejection fraction (HFrEF) 1
Session
Heart failure with reduced ejection fraction (HFrEF) 1
21 May 2023
Heart failure with reduced ejection fraction (HFrEF) 3
Session
Heart failure with reduced ejection fraction (HFrEF) 3
21 May 2023

ESC 365 is supported by